Serum branch-chained amino acids are increased in type 2 diabetes and associated with atherosclerotic cardiovascular disease.

"Declarations Ethics approval and consent to participateThis study was approved by the Ethical and Clinical Investigation Committee of the Pere Virgili Institute for Health Research (IISPV) and fulfilled the principles of the Helsinki Declaration. All the participants included in the study signed a written consent. Consent for publicationWe agree that the data are original and not currently under review elsewhere, and we consent to their publication. Competing interestsNúria Amigó is CEO and co-founder of Biosfer Teslab SL. The rest of the authors declare that there were no financial or commercial relations that may be viewed as potential conflicts of interest. Competing interests Núria Amigó is CEO and co-founder of Biosfer Teslab SL. The rest of the authors declare that there were no financial or commercial relations that may be viewed as potential conflicts of interest."

"Funding Grants from the Instituto de Salud Carlos III (ISCIII, Madrid, Spain) were used to support this work (PI18/00515). The Spanish Biomedical Research Centre in Diabetes and Associated Metabolic Disorders (CIBERDEM) jointly provided national funding. The European Regional Development Fund (ERDF) co-funded this project."